Glyhill 1mg/500mg/0.2mg Tablet SR
Marketer
Daffohils Laboratories Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glyhill 1mg/500mg/0.2mg Tablet SR
Diabetam 1mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Diabetam 1mg/500mg/0.2mg Extended-Release Tablets should be administered with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar or feeling well; abrupt cessation without medical consultation risks elevated blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive treatment plan encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most common adverse effect, characterized by sweating, dizziness, headache, and tremors. Prompt recognition and treatment are essential; maintain regular mealtimes and carry a fast-acting glucose source like sugary foods or juice. Alcohol consumption elevates hypoglycemia risk and should be avoided. Other potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals must consult their doctor before use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.
Primary Ingredients of Glyhill 1mg/500mg/0.2mg Tablet SR
No text provided. Please provide the text you wish me to rephrase.
Uses of Glyhill 1mg/500mg/0.2mg Tablet SR
Managing Type 2 diabetes
Major Benefits of Glyhill 1mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Glyhill 1mg/500mg/0.2mg Extended-Release Tablets should be administered on an empty stomach.
Common Side effects of Glyhill 1mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glyhill 1mg/500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glyhill 1mg/500mg/0.2mg SR tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Glyhill 1mg/500mg/0.2mg Tablet SR works:
Each Glyhill SR tablet (1mg/500mg/0.2mg) combines three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glyhill 1mg/500mg/0.2mg SR tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Glyhill 1mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Consult your doctor for advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glyhill tablets (1mg/500mg/0.2mg) are likely not suitable for use while breastfeeding. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Glyhill 1mg/500mg/0.2mg sustained-release tablets are likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is necessary. Furthermore, their use is discouraged in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Glyhill 1mg/500mg/0.2mg SR tablets cautiously, as dosage modification may be necessary. Individuals with mild to moderate liver disease should begin with a low dose; however, this medication is unsuitable for those with severe liver dysfunction. Consult a physician for guidance.
What if you forget to take Glyhill 1mg/500mg/0.2mg Tablet SR :
Should you forget to take a Glyhill 1mg/500mg/0.2mg SR tablet, administer it immediately upon remembering. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glyhill 1mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Medication |
3,018 People bought this recently